Mereo Biopharma Group Plc(GB:0A9G)
$0.30-0.01 (-1.96%)
GB:0A9G
Mereo Biopharma Group Plc financials statements
$0.30
At close:-0.01 (-1.96%)
Mereo Biopharma Group Plc (0A9G) Financial Statements
1 Followers
Mereo Biopharma Group Plc Financial Overview
Mereo Biopharma Group Plc's market cap is currently $48.96M. The company's EPS TTM is $-0.18; its P/E ratio is -1.71; Mereo Biopharma Group Plc is estimated to report earnings on March 31, 2027, and the estimated EPS forecast is $-0.02. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 500.00K | $ 0.00 | $ 10.00M | $ 0.00 | $ 36.46M |
| Gross Profit | $ 367.00K | $ -1.09M | $ 7.43M | $ 1.15M | $ 18.56M |
| Operating Income | $ -38.26M | $ -47.38M | $ -28.42M | $ -54.43M | $ -20.94M |
| EBITDA | $ -40.47M | $ 1.09M | $ -26.06M | $ -37.87M | $ 18.91M |
| Net Income | $ -41.88M | $ -43.25M | $ -29.47M | $ -42.22M | $ 12.72M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 40.99M | $ 69.80M | $ 57.42M | $ 68.18M | $ 127.52M |
| Total Assets | $ 45.92M | $ 76.39M | $ 66.50M | $ 77.41M | $ 170.96M |
| Total Debt | $ 202.00K | $ 6.43M | $ 5.95M | $ 15.37M | $ 22.66M |
| Net Debt | $ -40.79M | $ -63.37M | $ -51.47M | $ -52.81M | $ -104.08M |
| Total Liabilities | $ 5.00M | $ 15.42M | $ 15.96M | $ 26.01M | $ 51.95M |
| Stockholders' Equity | $ 40.92M | $ 60.97M | $ 50.54M | $ 51.40M | $ 119.01M |
| Cash Flow | |||||
| Free Cash Flow | $ -30.99M | $ -33.53M | $ -21.55M | $ -48.83M | $ -7.79M |
| Operating Cash Flow | $ -30.97M | $ -32.83M | $ -21.13M | $ -48.82M | $ -7.07M |
| Investing Cash Flow | $ -20.00K | $ -699.00K | $ -419.00K | $ 1.99M | $ -568.20K |
| Financing Cash Flow | $ 327.00K | $ 46.15M | $ 7.97M | $ 200.00K | $ 104.80M |
Currency in USD
